Ilaris NIS in Korea — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ilaris NIS in Korea — Stella

Home/Hereditary Periodic Fever Syndromes/

View on ClinicalTrials.gov

Recruiting

Back to Hereditary Periodic Fever Syndromes trials

Trial locations(1 site)

South Korea

Novartis Investigative Site, Seoul

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~25 participants

Started

March 2025

Primary completion

September 2028

Age range

2 Years – 100 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.